Microfluidic digital isoelectric fractionation for rapid multidimensional glycoprotein analysis.

Area of Science:

• Biochemistry
• Analytical Chemistry
• Biotechnology

Background:

• Glycoprotein biomarkers are crucial for disease diagnosis.
• Current methods for glycoprotein analysis can be time-consuming and complex.
• There is a need for rapid, automated platforms for biomarker quantification.

Purpose of the Study:

• To develop an integrated microfluidic device for rapid and automated isolation and quantification of glycoprotein biomarkers.
• To demonstrate the device's capability for multidimensional analysis of protein isoforms.
• To assess the potential for clinical diagnostic applications.

Main Methods:

• Utilized a two-dimensional microfluidic platform combining digital isoelectric fractionation (dIEF) and monolithic column-based immunocapture.
• Employed dIEF with pH-specific membranes for high-resolution protein isoform separation and preconcentration.
• Integrated functionalized monolithic columns for targeted analyte capture and detection.

Main Results:

• Successfully fractionated isoforms of fetuin and prostate-specific antigen (PSA) within a 10-minute run time.
• Demonstrated rapid two-dimensional fractionation, immunocapture, and detection of C-reactive protein (CRP) in human serum.
• Achieved high-fidelity transfer of fractions for downstream analysis, comparable to conventional methods.

Conclusions:

• The developed microfluidic device offers a rapid, flexible, and automated approach for glycoprotein biomarker research.
• This technology is suitable for biomarker verification studies and holds promise for glycoprotein isoform-based diagnostic testing.
• The platform facilitates efficient multidimensional analysis of complex biological samples.